Painful acute thyroiditis following a first cure of Ipilimumab plus Nivolumab for metastatic melanoma

被引：2
|
作者：
Montaudie, Henri [1 ,2 ]
Picard, Alexandra [1 ]
Panaia-Ferrari, Patricia [3 ]
Boukari, Feriel [1 ]
Passeron, Thierry [1 ,2 ]
Sadoul, Jean-Louis [3 ]
Brucker-Davis, Francoise [3 ]
机构：
[1] Univ Hosp Nice, Archet 2 Hosp, Dept Dermatol, Nice, France
[2] INSERM, Ctr Mediterraneen Med Mol, Nice, France
[3] Cote Azur Univ, Univ Hosp Nice, Archet 2 Hosp, Dept Endocrinol Diabetol & Reprod Med, Nice, France
来源：
MELANOMA RESEARCH | 2018年 / 28卷 / 04期
关键词：
D O I：
10.1097/CMR.0000000000000460
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：368 / 369
页数：2
相关论文
共 50 条
  • [1] Acute Cholecystitis Following Ipilimumab and Nivolumab Treatment for Metastatic Melanoma
    Somerset, Amy E.
    Field, Bradley M.
    Webber, John D.
    Edelman, David A.
    AMERICAN SURGEON, 2023, 89 (02) : 312 - 313
  • [2] Metastatic Melanoma Nivolumab plus Ipilimumab is the better First-line Therapy
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (7-8) : 448 - 449
  • [3] Nivolumab (Opdivo) plus Ipilimumab (Yervoy) for Metastatic Melanoma
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1483): : 168 - 168
  • [4] Nivolumab plus Ipilimumab in Advanced Melanoma
    Wolchok, Jedd D.
    Kluger, Harriet
    Callahan, Margaret K.
    Postow, Michael A.
    Rizvi, Naiyer A.
    Lesokhin, Alexander M.
    Segal, Neil H.
    Ariyan, Charlotte E.
    Gordon, Ruth-Ann
    Reed, Kathleen
    Burke, Matthew M.
    Caldwell, Anne
    Kronenberg, Stephanie A.
    Agunwamba, Blessing U.
    Zhang, Xiaoling
    Lowy, Israel
    Inzunza, Hector David
    Feely, William
    Horak, Christine E.
    Hong, Quan
    Korman, Alan J.
    Wigginton, Jon M.
    Gupta, Ashok
    Sznol, Mario
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02): : 122 - 133
  • [5] Ipilimumab plus nivolumab for advanced melanoma
    Hassel, Jessica C.
    LANCET ONCOLOGY, 2016, 17 (11): : 1471 - 1472
  • [6] Nivolumab plus Ipilimumab in Advanced Melanoma
    Santhosh, Akhil
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (12): : 1245 - 1246
  • [7] Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
    Mansouri, Alireza
    Moraes, Fabio Y.
    Zadeh, Gelareh
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2177 - 2178
  • [8] Eosinophilic Pneumonia Following Treatment with Nivolumab-Ipilimumab for Metastatic Melanoma
    Wajda, N. A.
    Pina, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [9] Nivolumab plus ipilimumab for the first-line treatment of metastatic NSCLC
    Rijavec, Erika
    Indini, Alice
    Ghidini, Michele
    Tomasello, Gianluca
    Cattaneo, Monica
    Barbin, Francesca
    Grossi, Francesco
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (07) : 705 - 713
  • [10] Nivolumab plus ipilimumab in metastatic melanoma: a critical appraisal focused on specific subpopulations
    Vazquez-Montero, Lucia
    de la Gala, Maria del Carmen Alamo
    de la Cruz-Merino, Luis
    FRONTIERS IN ONCOLOGY, 2023, 13
12345